Trial intelligence / Profile preview

Miconazole + Domiphen Bromide for Acute VVC

NCT04813822Phase 2Unknown

Sponsor
Aesculape CRO
Start
Sep 2021
Primary completion
May 2022
Modality
Small Molecules
Countries
1
01

Overview

A Phase 2 trial of domiphen in vulvovaginal candidiasis (VVC), sponsored by Aesculape CRO. Status: unknown.

02

Drugs

domiphen
03

Conditions

vulvovaginal candidiasis (VVC)

Beyond the preview

Go deeper on NCT04813822.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT04813822.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call